Early measures of cognitive function predict survival in patients with newly diagnosed glioblastoma (Q34234748)

31 July 2017

title

Early measures of cognitive function predict survival in patients with newly diagnosed glioblastoma (English)

1 reference

31 July 2017

Derek R Johnson

1

1 reference

31 July 2017

Allison M Sawyer

2

1 reference

31 July 2017

Christina A Meyers

3

1 reference

31 July 2017

Brian Patrick O'Neill

4

1 reference

31 July 2017

Jeffrey S Wefel

5

1 reference

31 July 2017

publication date

16 April 2012

1 reference

31 July 2017

1 reference

31 July 2017

volume

14

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

808-816

1 reference

Exercise behavior, functional capacity, and survival in adults with malignant recurrent glioma

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Trail Making Test predicts physical impairment and mortality in older persons

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

MGMT gene silencing and benefit from temozolomide in glioblastoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Trail Making Test A and B: normative data stratified by age and education

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Demographic characteristics and normative observations for derived-trail making test indices

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Application of the Trail Making Test in differentiating neuropsychological impairment of elderly persons.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Neuropsychological deficits in symptomatic minor head injury patients after concussion and mild concussion

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3367851

Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network

6 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOS082

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOS082

Benton Controlled Oral Word Association Test: reliability and updated norms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOS082

The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOS082

Volumetric measurement of brain tumors from MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOS082

International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOS082

Outcome evaluation in glioblastoma patients using different ranking scores: KPS, GOS, mRS and MRC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOS082

Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. Clinical article

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOS082

Cognitive function as a predictor of survival in patients with recurrent malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOS082

The prognostic value of cognitive functioning in the survival of patients with high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOS082

Karnofsky performance status revisited: reliability, validity, and guidelines

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22508762

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/NEUONC/NOS082

1 reference

31 July 2017

1 reference

31 July 2017

1 reference